Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients.
about
Clinical Application of Human Urinary Extracellular Vesicles in Kidney and Urologic DiseasesWhen Prostate Cancer Circulates in the BloodstreamTumour exosomes display differential mechanical and complement activation properties dependent on malignant state: implications in endothelial leakinessUrothelial cells undergo epithelial-to-mesenchymal transition after exposure to muscle invasive bladder cancer exosomes.Laminin-binding integrin gene copy number alterations in distinct epithelial-type cancersExosomes from the tumor microenvironment as reciprocal regulators that enhance prostate cancer progression.The αvβ6 integrin is transferred intercellularly via exosomesTherapeutic applications of extracellular vesicles: clinical promise and open questions.Exosomes serve as tumour markers for personalized diagnostics owing to their important role in cancer metastasis.mPGES-1 in prostate cancer controls stemness and amplifies epidermal growth factor receptor-driven oncogenicity.Epidermal Growth Factor Receptor in Prostate Cancer Derived Exosomes.Non‑invasive prostate cancer detection by measuring miRNA variants (isomiRs) in urine extracellular vesicles.The emerging role of extracellular vesicles as biomarkers for urogenital cancers.Coupling enrichment methods with proteomics for understanding and treating disease.The emerging role of exosomes in epithelial-mesenchymal-transition in cancer.Urinary extracellular vesicles as source of biomarkers in kidney diseases.Tracing Cellular Origin of Human Exosomes Using Multiplex Proximity Extension Assays.Cell-derived extracellular vesicles as a platform to identify low-invasive disease biomarkers.Role of exosomes and microvesicles in hypoxia-associated tumour development and cardiovascular disease.The contribution of tumour-derived exosomes to the hallmarks of cancer.Myosin isoform expressed in metastatic prostate cancer stimulates cell invasion.Exosome-mediated Transfer of αvβ3 Integrin from Tumorigenic to Nontumorigenic Cells Promotes a Migratory Phenotype.Extracellular vesicles in blood, milk and body fluids of the female and male urogenital tract and with special regard to reproduction.Extracellular Vesicles in Renal Pathophysiology.Feasibility of urinary extracellular vesicle proteome profiling using a robust and simple, clinically applicable isolation method.Exosomes confer pro-survival signals to alter the phenotype of prostate cells in their surrounding environmentTrop-2 is up-regulated in invasive prostate cancer and displaces FAK from focal contacts.Metabolomic Profiling of Extracellular Vesicles and Alternative Normalization Methods Reveal Enriched Metabolites and Strategies to Study Prostate Cancer-Related Changes.Exosomes in diagnosis and therapy of prostate cancer.The key role of extracellular vesicles in the metastatic process.Exosomes: Nanocarriers of Biological Messages.Protein Complexes in Urine Interfere with Extracellular Vesicle Biomarker Studies.Proteomes, Their Compositions and Their Sources.Large-Scale Urinary Proteome Dataset Across Tumor Types Reveals Candidate Biomarkers for Lung Cancer.Extracellular Vesicles in Prostate Cancer Carcinogenesis, Diagnosis, and Management.Fatty Acids and Calcium Regulation in Prostate Cancer.
P2860
Q26744741-D70CB417-37C8-40FC-A90D-76E770B45725Q26768470-85068030-725F-4246-9A14-BAA521AE2A34Q27303307-6758FE86-02EE-4C8B-8A0E-C019C9396FCAQ27309880-C52BBC09-798C-427F-8333-A3B0D0C7A582Q30489312-866716E3-6DBE-43D1-86EF-9B3340FE02F1Q33363486-65D41013-599B-4ECD-8F31-28CAB888A2C6Q35103855-89176FFB-BAC2-4A41-89EE-56FC9163E3D7Q35654719-3D4E7358-C4CE-4864-B5A4-8F78634D5453Q35763548-1999B7A4-373B-49FF-AE54-46BCD6273495Q35921941-BD53305D-43B7-4CA0-85BA-F9D8DEB4B468Q36010700-96123835-6BD4-43D8-BE2A-C600871BF986Q37225603-B5923CE2-AA5A-4FB5-B488-D19AFEDE6678Q38268801-6287DC73-3EBC-48C2-B7B3-04BC2E8ED7BCQ38293824-3862650C-234E-4D89-93C0-A2353D638074Q38310370-DB04DB5D-ABC0-4AFE-A8DB-ECD46EE85551Q38358073-7194F977-EE61-4D70-A9EE-31AB529476ABQ38374002-6C544D62-EC53-4678-A40B-AF7CBA1EB9A1Q38463053-FF951029-682A-44C6-8CDA-5F2E312840A2Q38543812-BF05AEBB-62B8-4DD9-916D-42BF14BE2776Q38610872-CF5BC0BF-09CF-4807-8C0D-B329EDA3F3D6Q38621389-5E704F3F-2916-48A7-BC53-92057736819AQ38756785-D82E2167-40C8-45B7-9DE2-09A88DAF799DQ38837378-33C00298-4432-4EF7-B0B1-69E8D2D59B57Q39389732-3ADED453-CC91-4BA3-9519-3791DE24DD47Q40980080-40C81B01-5B63-4953-9F9C-1EE73C132105Q42262721-4706555B-1766-4F14-B022-58205A0B4E9FQ42747405-4D2410E0-B0F2-4294-89AA-09AE1F6B08D7Q47103101-DCC8D34A-D43D-455D-9586-3E20F1CBE63DQ47117604-1752247D-3DFC-4C14-8BCD-34442ADCC261Q47314287-D927C6EF-8197-414D-93C8-EF206314F7A4Q47763464-94091D35-A56A-430F-BA23-72BBC496B69EQ50890816-2489CEA2-586A-42A8-92CD-2DDDA6C8C3CAQ51263649-E3CB6F72-D8FB-4312-B1C0-E1562C583AB7Q55110309-8ABDB8A5-997E-4716-9655-618860FB353AQ55342189-B9C900C1-4473-4571-8E60-D0D6B897E363Q55468609-4AD3CAF1-345E-4AA1-9739-82B4DD611662
P2860
Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Exosomal ITGA3 interferes with ...... atic prostate cancer patients.
@en
Exosomal ITGA3 interferes with ...... atic prostate cancer patients.
@nl
type
label
Exosomal ITGA3 interferes with ...... atic prostate cancer patients.
@en
Exosomal ITGA3 interferes with ...... atic prostate cancer patients.
@nl
prefLabel
Exosomal ITGA3 interferes with ...... atic prostate cancer patients.
@en
Exosomal ITGA3 interferes with ...... atic prostate cancer patients.
@nl
P2093
P2860
P356
P1476
Exosomal ITGA3 interferes with ...... atic prostate cancer patients.
@en
P2093
Albert A Geldof
Connie R Jimenez
Irene V Bijnsdorp
Mehrdad Lavaei
R Jeroen A van Moorselaar
Sander R Piersma
P2860
P356
10.3402/JEV.V2I0.22097
P577
2013-12-23T00:00:00Z